Biogen annual gross margin
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Biogen's gross margin was 86.57% for fiscal 2020.
View full Biogen company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2020 | 2020-12-31 | 86.57% | +0.17 pp |
| 2019 | 2019-12-31 | 86.40% | −0.10 pp |
| 2018 | 2018-12-31 | 86.50% | −0.22 pp |
| 2017 | 2017-12-31 | 86.72% | −0.36 pp |
| 2016 | 2016-12-31 | 87.08% | −1.39 pp |
| 2015 | 2015-12-31 | 88.48% | +0.54 pp |
| 2014 | 2014-12-31 | 87.93% | +0.30 pp |
| 2013 | 2013-12-31 | 87.63% | −2.48 pp |
| 2012 | 2012-12-31 | 90.11% | −0.64 pp |
| 2011 | 2011-12-31 | 90.76% | −0.76 pp |
| 2010 | 2010-12-31 | 91.51% | +0.24 pp |
| 2009 | 2009-12-31 | 91.27% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|
Over the last five reported fiscal years, Biogen's gross margin decreased from 88.48% to 86.57%, a change of −1.90 percentage points.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biogen filings at SEC.gov ↗